Ashrayam Pharmaceutical Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -8.90%
(FY 2017)
- Profit -9.54%
(FY 2017)
- Ebitda 5.60%
(FY 2017)
- Net Worth -6.14%
(FY 2017)
- Total Assets 49.39%
(FY 2017)
About Ashrayam Pharmaceutical Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammed Ali and Safiya Nadakkavil serve as directors at the Company.
- CIN/LLPIN
U52311KL2008PTC022125
- Company No.
022125
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ashrayam Pharmaceutical Distributors?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Safiya Nadakkavil  | Managing Director | 25-Mar-2008 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohammed Ali | Director | 29-Jun-2015 | Current |
Financial Performance of Ashrayam Pharmaceutical Distributors.
Ashrayam Pharmaceutical Distributors Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 8.9% decrease. The company also saw a slight decrease in profitability, with a 9.54% decrease in profit. The company's net worth dipped by a decrease of 6.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ashrayam Pharmaceutical Distributors?
In 2017, Ashrayam Pharmaceutical Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nadakkavil Hospital Private LimitedActive 6 years 8 monthsMohammed Ali and Safiya Nadakkavil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ashrayam Pharmaceutical Distributors?
Unlock and access historical data on people associated with Ashrayam Pharmaceutical Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ashrayam Pharmaceutical Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ashrayam Pharmaceutical Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
